Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Intangibles (2023 - 2025)

Tonix Pharmaceuticals Holding has reported Intangibles over the past 3 years, most recently at $120000.0 for Q4 2025.

  • Quarterly results put Intangibles at $120000.0 for Q4 2025, changed 0.0% from a year ago — trailing twelve months through Dec 2025 was $120000.0 (changed 0.0% YoY), and the annual figure for FY2025 was $120000.0, changed 0.0%.
  • Intangibles for Q4 2025 was $120000.0 at Tonix Pharmaceuticals Holding, roughly flat from $120000.0 in the prior quarter.
  • Over the last five years, Intangibles for TNXP hit a ceiling of $10.2 million in Q2 2023 and a floor of $120000.0 in Q4 2023.
  • Median Intangibles over the past 3 years was $120000.0 (2023), compared with a mean of $1.9 million.
  • Peak annual rise in Intangibles hit 0.0% in 2024, while the deepest fall reached 98.83% in 2024.
  • Tonix Pharmaceuticals Holding's Intangibles stood at $120000.0 in 2023, then changed by 0.0% to $120000.0 in 2024, then changed by 0.0% to $120000.0 in 2025.
  • The last three reported values for Intangibles were $120000.0 (Q4 2025), $120000.0 (Q3 2025), and $120000.0 (Q2 2025) per Business Quant data.